Migraine

• FDA label_change · 2011-07-15
  FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  The FDA page documents a supplemental application for TOPAMAX (topiramate) submitted by Janssen Pharmaceuticals, related to labeling changes…

• FDA label_change · 2011-06-23
  FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Supplemental Application (Actavis Pharma, Inc.)

  FDA documents a supplemental application for the generic combination butalbital, acetaminophen, and caffeine, indicating changes to the prod…

• FDA label_change · 2010-09-10
  FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for divalproex sodium submitted by Mylan Pharmaceuticals Inc., resulting in a labeling update.

• FDA label_change · 2007-02-21
  FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc., resulting in labe…

• FDA label_change · 2006-10-13
  FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)

  The FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie Inc. This action relates to changes impleme…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.